Home/Pipeline/Avioq HTLV-I/II Microelisa System

Avioq HTLV-I/II Microelisa System

HTLV-I/II screening in blood donors

ApprovedActive

Key Facts

Indication
HTLV-I/II screening in blood donors
Phase
Approved
Status
Active
Company

About Avioq

Avioq is a US-based, private diagnostic company and CDMO founded in 2005 and headquartered in Research Triangle Park, North Carolina. It has a portfolio of FDA-approved and CE-marked assays for HIV and HTLV and leverages its regulatory expertise and certified manufacturing facility to offer end-to-end IVD development and manufacturing services to other companies. The company's business model combines revenue from its own commercial diagnostic products with fee-for-service CDMO work, positioning it in the growing market for outsourced IVD development and direct-to-consumer testing.

View full company profile

Therapeutic Areas